Wen‐Chien Cheng

Comparison of the effects of the three major tyrosine kinase inhibitors as first-line therapy for non-small-cell lung cancer harboring epidermal growth factor receptor mutations

Chih‐Yen Tu, Chuan‐Mu Chen, Wei‐Chih Liao et al. · Oncotarget · 2018 · 32 citations · Full text

Medicine, Oncology, Pharmacology +16

(−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma

I‐Ta Lu, Shih‐Chao Lin, Yi-Chia Chu et al. · Marine Drugs · 2022 · 20 citations · Full text

Medicine, Oncology, Pharmacology +13

Outcomes and Prognostic Factors in Critical Patients with Hematologic Malignancies

Chieh‐Lung Chen, Sing-Ting Wang, Wen‐Chien Cheng et al. · Journal of Clinical Medicine · 2023 · 14 citations · Full text

Medicine, Hematology, Oncology +13

Correlating Reiff scores with clinical, functional, and prognostic factors: characterizing noncystic fibrosis bronchiectasis severity: validation from a nationwide multicenter study in Taiwan

Wen‐Chien Cheng, Chia‐Ling Chang, Chau‐Chyun Sheu et al. · European journal of medical research · 2024 · 13 citations · Full text

Medicine, Clinical Sciences, Radiology +17

The optimal therapy strategy for epidermal growth factor receptor<scp>‐mutated non‐small cell</scp> lung cancer patients with brain metastasis: A <scp>real‐world</scp> study from Taiwan

Wen‐Chien Cheng, Yi‐Cheng Shen, Chun‐Ru Chien et al. · Thoracic Cancer · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacotherapy +17